It is the internal testing website that you are visiting. Please go to our official customer website (www.myplaniq.com).
Find A Portfolio/Ticker
Comparison Box
RYBOX: BIOTECHNOLOGY FUND CLASS A (MUTUAL FUND)
Basic Info 65.4 1.01(1.52%) June 05
| Asset Class: | Health |
| MyPlanIQ Rating: | (47%) |
| Start Date: | 09/01/2004 |
| Last Dividend Date: | 12/16/2025 |
| 12-Mo. Yield | 17.85% |
| Expenses | 1.36% |
| Sign up to get fund ranking change alerts | |
Performance Analytics (As of 06/05/2026)
| Last 1 Week* | YTD*(2026) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Inception** | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return(%) | -1.7 | 6.0 | 41.0 | 13.4 | 5.0 | 8.0 | 11.7 | 10.9 | 10.6 | 30.3 | -1.2 | 5.8 | -13.3 | 1.8 | 21.6 | 24.7 | -9.2 | 29.4 | -19.7 | 8.5 | 33.2 | 54.3 | 36.2 | 11.1 | 9.1 | 20.4 | -10.8 | 5.5 | -3.4 | 11.5 | 8.3 |
| Sharpe Ratio | NA | 0.54 | 1.96 | 0.42 | 0.1 | 0.26 | NA | NA | 0.38 | 1.24 | -0.17 | 0.13 | -0.53 | 0.08 | 0.64 | 1.13 | -0.42 | 1.69 | -0.66 | 0.29 | 1.18 | 2.59 | 1.85 | 0.42 | 0.43 | 0.79 | -0.33 | 0.14 | -0.41 | 0.49 | 1.26 |
| Draw Down(%) | NA | 8.5 | 8.5 | 30.4 | 33.8 | 33.8 | NA | NA | 40.8 | 19.9 | 19.6 | 15.3 | 27.1 | 15.2 | 24.8 | 16.5 | 25.5 | 7.4 | 28.1 | 28.3 | 23.3 | 10.2 | 12.1 | 24.1 | 22.0 | 21.4 | 34.9 | 11.5 | 19.1 | 13.9 | 11.1 |
| Standard Deviation(%) | NA | 22.1 | 19.5 | 24.0 | 23.8 | 24.4 | NA | NA | 24.5 | 22.2 | 29.5 | 16.8 | 27.8 | 21.3 | 33.3 | 20.6 | 25.3 | 17.1 | 30.2 | 29.3 | 28.1 | 20.9 | 19.7 | 26.6 | 21.1 | 25.8 | 35.1 | 16.5 | 16.8 | 18.8 | 20.3 |
| Treynor Ratio | NA | 0.1 | 0.36 | 0.09 | 0.02 | 0.05 | NA | NA | 0.07 | 0.26 | -0.04 | 0.02 | -0.12 | 0.01 | 0.19 | 0.18 | -0.08 | 0.22 | -0.12 | 0.06 | 0.19 | 0.34 | 0.24 | 0.09 | 0.07 | 0.18 | -0.11 | 0.02 | -0.05 | 0.06 | 0.17 |
| Alpha | NA | 0.07 | 0.06 | 0.04 | 0.0 | 0.0 | NA | NA | 0.0 | 0.04 | 0.02 | 0.0 | -0.04 | -0.06 | 0.03 | -0.01 | -0.03 | 0.03 | -0.02 | -0.03 | -0.05 | -0.05 | 0.04 | -0.01 | 0.01 | 0.0 | 0.05 | 0.01 | -0.06 | -0.04 | -0.02 |
| Beta | NA | 1.19 | 1.06 | 1.12 | 1.16 | 1.2 | NA | NA | 1.25 | 1.05 | 1.16 | 1.15 | 1.23 | 1.33 | 1.1 | 1.29 | 1.41 | 1.29 | 1.67 | 1.48 | 1.74 | 1.6 | 1.49 | 1.27 | 1.35 | 1.11 | 1.06 | 1.19 | 1.38 | 1.58 | 1.5 |
| RSquared | NA | 0.71 | 0.66 | 0.44 | 0.54 | 0.63 | NA | NA | 0.64 | 0.67 | 0.21 | 0.64 | 0.79 | 0.49 | 0.83 | 0.7 | 0.77 | 0.56 | 0.79 | 0.73 | 0.64 | 0.64 | 0.57 | 0.75 | 0.68 | 0.63 | 0.74 | 0.62 | 0.58 | 0.52 | 0.6 |
| Yield(%) | N/A | 0.0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 17.1 | 14.4 | 0.0 | 1.3 | 18.6 | 9.2 | 5.6 | 12.0 | 7.0 | 0.0 | 1.6 | 5.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Dividend Growth(%) | N/A | -100.0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.2 | N/A | -100.0 | -94.3 | 126.9 | 93.0 | -63.6 | 110.6 | N/A | -100.0 | -59.6 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 08/31/2004
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
|
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (VANGUARD HEALTH CARE FUND INVESTOR SHARES) (97%)
- HGHAX (THE HARTFORD HEALTHCARE FUND CLASS A) (79%)
- FSMEX (MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO) (78%)
- FBIOX (BIOTECHNOLOGY PORTFOLIO BIOTECHNOLOGY PORTFOLIO) (77%)
- FBTIX (FIDELITY ADVISOR BIOTECHNOLOGY FUND CLASS I) (77%)
- FPHAX (PHARMACEUTICALS PORTFOLIO PHARMACEUTICALS PORTFOLIO) (75%)
- FSHCX (HEALTH CARE SERVICES PORTFOLIO HEALTH CARE SERVICES PORTFOLIO) (74%)
- FSPHX (HEALTH CARE PORTFOLIO HEALTH CARE PORTFOLIO) (74%)
- FHCIX (FIDELITY ADVISOR HEALTH CARE FUND CLASS I) (73%)
- SHSSX (BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO INSTITUTIONAL) (66%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR Fund) (96%)
- BBH (VanEck Biotech ETF) (94%)
- IBB (iShares Biotechnology ETF) (94%)
- PPH (VanEck Pharmaceutical ETF) (94%)
- FBT (First Trust NYSE Arca Biotechnology Index Fund) (91%)
- FXH (First Trust Health Care AlphaDEX Fund) (90%)
- IHE (iShares U.S. Pharmaceuticals ETF) (88%)
- IHF (iShares U.S. Healthcare Providers ETF) (88%)
- IHI (iShares U.S. Medical Devices ETF) (88%)
Best Closed End Funds
- BME (BlackRock Health Sciences Trust) (100%)
- GRX (Gabelli Healthcare & WellnessRx Trust) (99%)
- HQH (Tekla Healthcare Investors) (98%)
- HQL (Tekla Life Sciences Investors) (98%)
